The FDA granted clearance for Nextremity Solutions to market its InCore Lapidus system.

The device is used to stabilize and correct multi-planar deformities while giving visibility for the surgeon’s preferred joint preparation during Lapidus procedures.

It is indicated as a three-part construct meant for internal fixation for First Metatarsocuneiform Arthrodesis (Lapidus or Tarsometatarsal Fusion), and has an application pending for a CE Mark.